malignant pleural effusions的意思|示意
恶性肿瘤性胸腔积液，恶性胸腔积液
malignant pleural effusions的网络常见释义
恶性胸腔积液 恶性胸腔积液（malignant pleural effusions）是恶性肿瘤转移或胸膜原发肿瘤所致的胸腔积液。肺癌、乳癌、淋巴瘤是恶性胸腔积液的最常见的三大原因，约占恶性胸腔积液的75%[1]...
恶性肋膜积液 恶性肋膜积液(Malignant Pleural Effusions)： 最常用在乳癌、卵巢癌及淋巴癌造成恶性肋膜积液。
malignant pleural effusions相关短语
1、 exudative malignant pleural effusions 渗出性恶性胸腔积液
2、 malignant pleural effusions or ascites 恶性胸腹腔积液
malignant pleural effusions相关例句
Such pleural metastases may lead to pleural effusions, including hemorrhagic effusions, and pleural fluid cytology can often reveal the malignant cells.
可引起胸腔积液，包括出血性的渗出物，并且胸水细胞学检查可见癌细胞。
Therapeutic effectiveness:the response rate of malignant pleural effusions was 78.4%(80/102 cases).
疗效：恶性胸腔积液102 例，近期胸腔积液消失80 例（78.4%）。
Objective: To study the therapeutic efficacy of intrapersonal injection of cisplatin(DDP) and interleukin-2(IL-2) in malignant pleural effusions.
目的：探讨胸腔注入顺铂（DDP）联合白细胞介素一2（IL-2）治疗恶性胸腔积液疗效。
Conclusions Ultrasonography is helpful in diagnosis and differentiation of tuberculous and malignant pleural effusions.
结论超声检查对结核性和恶性胸腔积液的鉴别诊断有一定临床意义。
Objectives to investigate the diagnostic value of DNA analysis and combined with Carcinoembryonic antigen (CEA) for malignant pleural effusions by FlowCytometry (FCM).
目的应用流式细胞术(FCM)测定胸液细胞DNA倍体，并同时检测胸液癌胚抗原(CEA)水平，以探讨其在恶性胸液诊断中的价值。
Conclusion The LDH can be used as an indicator to distinguish tuberculosis pleural effusion from malignant pleural effusions.
结论胸水中L DH检测对区别结核性与癌性胸水有帮助。